Antiviral agents: clinical status report.

Recently, the clinical focus in antiviral chemotherapy has been on the use of ara-A in herpes infections-HSV encephalitis, zoster in the immunosuppressed, and neonatal herpes. In this last article of a four-part series, the authors review clinical studies that have to date led to the licensing of ara-A for HSV encephalitis but have not yet clearly defined its role in the immunosuppressed or in neonates.
AuthorsR J Whitley, C A Alford
JournalHospital practice (Office ed.) (Hosp Pract (Off Ed)) Vol. 16 Issue 7 Pg. 109-21 (Jul 1981) ISSN: 8750-2836 [Print] UNITED STATES
PMID6788666 (Publication Type: Journal Article)
Chemical References
  • Vidarabine
  • Encephalitis (diagnosis, drug therapy)
  • Herpes Simplex (diagnosis, drug therapy)
  • Herpes Zoster (diagnosis, drug therapy)
  • Humans
  • Immunosuppression
  • Infant, Newborn
  • Infant, Newborn, Diseases (diagnosis, drug therapy)
  • Prognosis
  • Vidarabine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: